A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy (Q80251510)
Jump to navigation
Jump to search
scientific article published on 02 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy |
scientific article published on 02 May 2007 |
Statements
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy (English)
George Dranitsaris
Wei Ooi